2-year results of telbivudine (LDT) roadmap study verify the optimal efficacy and safety results in HBeAg positive chronic hepatitis B (CHB) patients
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListPIRATVISUTH T, KOMOLMET P, TANWANDEE T, SUKEEPAISARNJAOREN W, CHAN Lik Yuen Henry, PESSOA Mg, PESSOA Mg, FASSIO E, ONO-NITA S, BESSONE F, DARUICH J, ZEUZEM S, CHEINQUER H, DONG Y, TRYLESINSKI A
Name of Conferenceannual meeting of European Association for the Study of the Liver
Proceedings Titleannual meeting of European Association for the Study of the Liver
Detailed descriptionorganized by EASL,
Year2012
Month4
Pages1
LanguagesEnglish-United Kingdom

Last updated on 2018-20-01 at 15:17